Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Jinxin Fertility Group Ltd. ( (HK:1951) ).
Jinxin Fertility Group Ltd. has issued a profit warning, anticipating a loss of up to RMB1,090 million for the first half of 2025, primarily due to impairments and provisions related to its operations in the United States and Laos. Despite these challenges, the company remains confident in its long-term growth prospects, citing strong industry foundations and supportive national policies. Additionally, the company has appointed Mr. Dong Yang as the acting chief financial officer, who will oversee financial management and business development.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.33 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the fertility industry, providing reproductive medical services. The company focuses on enhancing clinical treatment results, patient care, and service offerings, supported by favorable national policies and a solid industry foundation.
Average Trading Volume: 78,900,795
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.84B
For an in-depth examination of 1951 stock, go to TipRanks’ Overview page.